All locations are open. Call your doctor today to schedule an in-person appointment or a doctor video visit.
Learn about our COVID-SAFE Care • Latest Visitor Policy and Service Updates • Donate and Lend Support


Todos los centros abiertos. Llame al médico hoy para una cita en persona o para una video visita médica.
Sepa qué es la Salud A SALVO DE COVID • Novedades de servicios y normas de visitas • Done y dé apoyo

Learn more
Search Clinical Trials
Home >  Clinical Trials & Research >  Search Clinical Trials
Print

Clinical Trials & Research

Search Clinical Trials

Clinical Trials

New Search
Title   A 24 Week, Multicenter, Randomized, Double-Blind, Parallel Group, Phase 3 Trial with a 28 Week Long Term Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 10 mg in T2DM Patients aged 10-24 years.
Full Title   A 24 Week, Multicenter, Randomized, Double-Blind, Parallel Group, Phase 3 Trial with a 28 Week Long Term Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 10 mg in T2DM Patients aged 10-24 years.
Disease/Condition   Pediatric Endocrinology
Description  

Click here for more information

Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Rubina Heptulla
Contact Name   Ranjitha Katikaneni
Contact Email   rkatikan@montefiore.org
Protocol Number   IRB# 16-10-255-01
Inclusion/Notes   This information was obtained from ClinicalTrials.gov.
Status   Enrolling
Adult Clinical Trial   No
Pediatric Clinical Trial   No
Adult, Pediatric, Both   Adult